These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 13388821)

  • 1. [Prolonged coagulation time following intravenous administration of 6% dextran solution].
    MOLKE W
    Pol Tyg Lek (Wars); 1956 Aug; 11(33):1462-3. PubMed ID: 13388821
    [No Abstract]   [Full Text] [Related]  

  • 2. Further studies of a hemostatic defect caused by intravenous dextran.
    ADELSON E; CROSBY WH; ROEDER WH
    J Lab Clin Med; 1955 Mar; 45(3):441-8. PubMed ID: 14354329
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of suboptimal concentrations of sodium citrate upon the clotting times of human and dog blood after intravenous administration of heparin.
    LOSNER S; VOLK BW
    Am J Med Sci; 1952 Dec; 224(6):673-8. PubMed ID: 12996513
    [No Abstract]   [Full Text] [Related]  

  • 4. Some effects of low molecular weight dextran on coagulation.
    Dugdale M; Nofzinger JD; Murphey F
    Thromb Diath Haemorrh; 1966 Jan; 15(1):118-30. PubMed ID: 5919795
    [No Abstract]   [Full Text] [Related]  

  • 5. Disordered blood coagulation in burned children receiving high molecular weight dextran.
    Thomas T; Morris A; Rose MS
    J Clin Pathol; 1972 Jun; 25(6):473-7. PubMed ID: 5043372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the intravenous administration of dextran on cardiac output and other circulatory dynamics.
    WITHAM AC; FLEMING JW; BLOOM WL
    J Clin Invest; 1951 Sep; 30(9):897-902. PubMed ID: 14880616
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of Polfa dextran-40 on blood clotting system in thrombelastographic and laboratory studies].
    Badowski A; Stanowski E; Daciewicz Z; Pelasa J
    Pol Przegl Chir; 1973 Apr; 45(4):445-52. PubMed ID: 4699770
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the effect of dextran on the coagulation of blood.
    JACOBAEUS U
    Acta Med Scand Suppl; 1957; 322():3-103. PubMed ID: 13434798
    [No Abstract]   [Full Text] [Related]  

  • 9. [The modification of the pre-phase of coagulation by Dextran 150. II. In vivo studies on rabbits].
    Graeff H; Kuhn W
    Klin Wochenschr; 1966 Jun; 44(11):646-50. PubMed ID: 5987970
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies with crystalline trypsin: results and hazards of intravenous administration and its postulated role in blood coagulation.
    TAYLOR A; OVERMAN RS; WRIGHT IS
    J Am Med Assoc; 1954 May; 155(4):347-51. PubMed ID: 13151926
    [No Abstract]   [Full Text] [Related]  

  • 11. [The modification of the prephase of coagulation with dextran 150 in vitro].
    Kuhn W; Graeff H
    Klin Wochenschr; 1965 Dec; 43(23):1281-2. PubMed ID: 5872353
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of intravenous administration of fat emulsions and their emulsifying agents. II. Effects of phosphatide preparations on the coagulation of the blood of dogs.
    KLEIN E; GARRETT JV; LEVER WF
    J Invest Dermatol; 1957 Apr; 28(4):321-4. PubMed ID: 13439225
    [No Abstract]   [Full Text] [Related]  

  • 13. [On blood coagulation following osmo-oncotherapy].
    Schmidt K; Reese L; Wolf P
    Anaesthesist; 1968 Jan; 17(1):13-7. PubMed ID: 5669457
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of dextran on the coagulation of blood; a preliminary report.
    JACOBAEUS U
    Acta Med Scand; 1955; 151(6):505-7. PubMed ID: 14398138
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of Sulfation and Molecular Weight on Anticoagulant Activity of Dextran.
    Drozd NN; Logvinova YS; Torlopov MA; Udoratina EV
    Bull Exp Biol Med; 2017 Feb; 162(4):462-465. PubMed ID: 28243911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding time prolongation after dextran infusion.
    ADELSON E
    Bibl Haematol; 1958; 7():275-6. PubMed ID: 13499277
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of intravenous administration of fat emulsions and their emulsifying agents. I. Effects on clearing factor activity, electrophoretic pattern and clotting time of blood of dogs.
    LEVER WF; BASKYS B
    J Invest Dermatol; 1957 Apr; 28(4):317-20. PubMed ID: 13439224
    [No Abstract]   [Full Text] [Related]  

  • 18. Coagulation system changes induced by pelvic surgery and the effect of Dextran 70.
    Bonnar J; Walsh JJ; Haddon M; Fairweather J; Denson KW
    Bibl Anat; 1973; 12():351-5. PubMed ID: 4597634
    [No Abstract]   [Full Text] [Related]  

  • 19. Dextran and prolonged bleeding time; results of a sixty-gram, one-liter infusion given to one hundred sixty-three normal human subjects.
    LANGDELL RD; ADELSON E; FURTH FW; CROSBY WH
    J Am Med Assoc; 1958 Jan; 166(4):346-51. PubMed ID: 13491344
    [No Abstract]   [Full Text] [Related]  

  • 20. An experimental study on the effect of plasma expanders on blood coagulability.
    Narita T; Matsumoto I; Kumazawa T; Ikezono E
    Bull Tokyo Med Dent Univ; 1979 Mar; 26(1):25-32. PubMed ID: 85502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.